Out-of-Distribution Detection as a Risk-Control Strategy for Medical Classification Machine Learning Models
Recent advancements in artificial intelligence and machine learning algorithms have significantly broadened their scope of application, including high-stakes medical contexts. However, the use of these algorithms in medical settings requires stringent guardrails to ensure their performance. Researchers from the U.S. Food and Drug Administration (FDA) have assessed the performance of state-of-the-art out-of-distribution (OOD) detection algorithms on three medical datasets with various modalities. Their findings suggest that OOD detection methods could help mitigate model risk when deploying medical AI in the real world.
Key Takeaways:
- Researchers from the U.S. Food and Drug Administration (FDA) assessed the performance of state-of-the-art OOD detection algorithms on three medical datasets of image, transcriptomics, and time series modalities.
- The use of OOD detection methods could help mitigate model risk when deploying medical AI in the real world, as per the research findings.
- Several OOD detectors consistently identified patients on which the model performed worse, suggesting that these methods can help identify model limitations.
- The research concluded that using OOD detection methods could improve the performance of medical AI models by filtering out patients on which the model has not been properly trained or tested.
Statistics:
- Three medical datasets of image, transcriptomics, and time series modalities were used in the research.
- Several OOD detectors consistently identified patients on which the model performed worse.
- OOD detection methods could help mitigate model risk when deploying medical AI in the real world.
Sources:
- Out-of-Distribution Detection as a Risk-Control Strategy for Medical Classification Machine Learning Models. Clinical and Translational Science, 2025;18(10).
- Clinical and Translational Science can be contacted at: Wiley, 111 River St, Hoboken 07030-5774, NJ, USA.